Francisco Barrera1, Lorena Azócar1, Héctor Molina1, Kurt A Schalper2, Marcia Ocares1, Jessica Liberona3, Luis Villarroel4, Fernando Pimentel5, Rosa M Pérez-Ayuso1, Flavio Nervi1, Albert K Groen6, Juan F Miquel1. 1. Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile. Santiago, Chile. 2. Anatomía Patológica, Facultad de Medicina, Pontificia Universidad Católica de Chile. Santiago, Chile. 3. Nutrición y Diabetes, Facultad de Medicina, Pontificia Universidad Católica de Chile. Santiago, Chile. 4. Salud Pública y Facultad de Medicina, Pontificia Universidad Católica de Chile. Santiago, Chile. 5. Cirugía Digestiva, Facultad de Medicina, Pontificia Universidad Católica de Chile. Santiago, Chile. 6. Department of Pediatrics and Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Abstract
UNLABELLED: Background and rationale for the study. FGF19/15 is a gut-derived hormone presumably governing bile acid (BA) synthesis and gallbladder (GB) refilling. FGF19 mRNA is present in human GB cholangiocytes (hGBECs); however, the physiological significance of GB-derived FGF19 remains unknown. We investigated whether hGBECs secrete FGF19 and the effects of cholecystectomy on serum FGF19 ([FGF19]s) and BA synthesis. MATERIAL AND METHODS: FGF19 expression was assessed by qRT-PCRs and immunostaining in hGBECs and terminal ileum, and quantified in bile and serum by ELISA. Basal and BA (chenodexycholic acid, CDCA) induced FGF19 expression and secretion was analyzed in primary cultured hGBECs and GB-d1 cell line. Pre and postprandial serum changes in [FGF19]s, 7α-hydroxy-4-cholestene-3-one (C4, a marker of BA synthesis) and BA were evaluated in plasma of gallstone disease patients at baseline and after cholecystectomy. RESULTS: FGF19 mRNA levels were ~250-fold higher in hGBECs compared to distal ileum. GB bile contained ~23-fold higher FGF19 levels compared to serum (p < 0.0001). CDCA induced dose-dependent expression and secretion of FGF19 in hGBECs and GB-d1 cells. Cholecystectomy increased plasma BA synthesis ≥ 2-fold (p < 0.0001), and altered the diurnal rhythm and significantly reduced [FGF19]s noon peak. BA serum levels, serum cholesterol and triglyceride content remained unchanged. CONCLUSIONS: In conclusion human GB cholangiocytes constitutively express and secrete high levels of FGF19 in a process regulated by BA. Resection of this organ doubles BA synthesis concomitantly with changes in [FGF19]s. These findings suggest a potential connection between GB cholangiocytes-derived FGF19 and BA metabolism that could lead to metabolic dysregulation following cholecystectomy.
UNLABELLED: Background and rationale for the study. FGF19/15 is a gut-derived hormone presumably governing bile acid (BA) synthesis and gallbladder (GB) refilling. FGF19 mRNA is present in human GB cholangiocytes (hGBECs); however, the physiological significance of GB-derived FGF19 remains unknown. We investigated whether hGBECs secrete FGF19 and the effects of cholecystectomy on serum FGF19 ([FGF19]s) and BA synthesis. MATERIAL AND METHODS:FGF19 expression was assessed by qRT-PCRs and immunostaining in hGBECs and terminal ileum, and quantified in bile and serum by ELISA. Basal and BA (chenodexycholic acid, CDCA) induced FGF19 expression and secretion was analyzed in primary cultured hGBECs and GB-d1 cell line. Pre and postprandial serum changes in [FGF19]s, 7α-hydroxy-4-cholestene-3-one (C4, a marker of BA synthesis) and BA were evaluated in plasma of gallstone diseasepatients at baseline and after cholecystectomy. RESULTS:FGF19 mRNA levels were ~250-fold higher in hGBECs compared to distal ileum. GB bile contained ~23-fold higher FGF19 levels compared to serum (p < 0.0001). CDCA induced dose-dependent expression and secretion of FGF19 in hGBECs and GB-d1 cells. Cholecystectomy increased plasma BA synthesis ≥ 2-fold (p < 0.0001), and altered the diurnal rhythm and significantly reduced [FGF19]s noon peak. BA serum levels, serum cholesterol and triglyceride content remained unchanged. CONCLUSIONS: In conclusion human GB cholangiocytes constitutively express and secrete high levels of FGF19 in a process regulated by BA. Resection of this organ doubles BA synthesis concomitantly with changes in [FGF19]s. These findings suggest a potential connection between GB cholangiocytes-derived FGF19 and BA metabolism that could lead to metabolic dysregulation following cholecystectomy.
Authors: Pirjo Käkelä; Ville Männistö; Imre Ilves; Maija Vaittinen; Milla-Maria Tauriainen; Matti Eskelinen; Helena Gylling; Hannu Paajanen; Jussi Pihlajamäki Journal: Obes Surg Date: 2017-05 Impact factor: 4.129
Authors: Lydia-Ann L S Harris; Gordon I Smith; Bettina Mittendorfer; J Christopher Eagon; Adewole L Okunade; Bruce W Patterson; Samuel Klein Journal: J Clin Endocrinol Metab Date: 2017-10-01 Impact factor: 5.958
Authors: Alexia Farrugia; Joseph Anthony Attard; Stuart Hanmer; Stuart Bullock; Siobhan McKay; Marwa Al-Azzawi; Roshneen Ali; Giles Bond-Smith; Ben Colleypriest; Sarah Dyer; Benjamin Masterman; Michael Okocha; Alan Osborne; Rikhilroy Patel; Mahmoud Sallam; Emmanuel Selveraj; Samar Shalaby; Wenrui Sun; Fraser Todd; Joel Ward; Rebecca Windle; Saboor Khan; Nigel Williams; Ramesh P Arasaradnam Journal: World J Surg Date: 2021-05-12 Impact factor: 3.352
Authors: Merel van den Broek; Loek J M de Heide; Fianne L P Sips; Martijn Koehorst; Tim van Zutphen; Marloes Emous; Martijn van Faassen; Albert K Groen; Natal A W van Riel; Jan F de Boer; André P van Beek; Folkert Kuipers Journal: Int J Obes (Lond) Date: 2021-01-15 Impact factor: 5.551